Pathological consequences of stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis may be related to the duration rather than to the intensity of HPA axis activation after exposure to the stressor. Consequently a fine analysis of post-stress events is of importance. The present experiments were designed to study the importance of three key factors in HPA recovery: intensity of the stressor (experiment 1), duration of exposure to the stressor (experiment 2) and previous experience of the animals with the situation (experiments 3 and 4). In experiment 1, analysis of both the response to the stressor and the poststress period showed that the stronger the stressor, the greater the area under the curve of HPA activation. In experiment 2, different groups of rats were exposed to different periods of immobilization (IMO) (20 min, 1 h and 2 h) and sampled before, during and after exposure to IMO. The speed of recovery of plasma corticotropin (ACTH) levels was not related to the duration of exposure to the stressor. In experiments 3 and 4, the influence of previous experience with the stressor was studied in rats daily exposed to 20 min IMO or daily injected with hypertonic saline (HS) for 8 days and sampled on days 1, 2, 5 and 8. Whereas a significant decline in plasma ACTH levels was not observed immediately after IMO until day 8, a single previous exposure to IMO was enough to enhance recovery 90 min after the end of exposure to IMO. Corticosterone levels were related to the number of previous experiences with the stressor only in the post-IMO period. In response to a novel stressor (forced swimming), chronic IMO rats showed a slightly impaired recovery as compared to stress-naive rats, suggesting that enhanced recovery of the HPA axis was specific for the homotypic stressor. After daily HS injections, a pattern similar to that after IMO was observed, the delayed, but not the early response of the HPA axis being reduced as a function of the number of previous experiences with the situation. Taken together, the present results suggest that the speed of recovery of the HPA axis after its activation by stressors is sensitive to the intensity of the stressors but not to their duration, and that adaptation to a repeated stressor is more apparent during the delayed HPA response.

1.
Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev 1984;5:25–44.
2.
Johnson EO, Kamilaris TC, Chrousos GP, Gold PW: Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev 1992;16:115–130.
3.
Roozendaal B, Carmi O, McGaugh JL: Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine. Proc Natl Acad Sci USA 1996;93:1429–1433.
4.
Lupien SJ, McEwen BS: The acute effects of corticosteroids on cognition: Integration of animal and human model studies. Brain Res Rev 1997;24:1–27.
5.
De Kloet R, Oitzl MS, Jeöls M: Stress and cognition: Are corticosteroids good or bad guys? Trends Neurosci 1999;22:422–426.
6.
De Kloet ER: Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991;12:95–164.
7.
Ratka A, Sutanto W, Bloemers M, De Kloet R: On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989;50:117–123.
8.
Jacobson L, Sapolsky R: Augmented ACTH response to stress in adrenalectomized rats replaced with constant, physiological levels of corticosterone are partially normalized by acute increase in corticosterone. Neuroendocrinology 1993;58:420–429.
9.
Reul J, Probst JC, Skutella T, Hirschmann M, Stec I, Montkowski A, Landgraf R, Holsboer F: Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisene mineralocorticoid receptor oligodeoxynucleotides. Neuroendocrinology 1997;65:189–199.
10.
Spencer RL, Kim PJ, Kalman BA, Cole MA: Evidence of mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 1998;139:2718–2726.
11.
Sapolsky RM, Krey LC, McEwen BS: Glucorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA 1984;81:6174–6177.
12.
Shanks N, Larocque S, Meaney MJ: Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: Early illness and later responsivity to stress. J Neurosci 1995;15:376–384.
13.
Meaney MJ, Diorio J, Francis D, Widdowson J, LaPlante P, Caldji C, Sharma S, Seckl JR, Plotsky PM: Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev Neurosci 1996;18:49–72.
14.
Vallée M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S: Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: Correlation with stress-induced corticosterone secretion. J Neurosci 1997;17:2626–2636.
15.
Seeman T, Robbins R: Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocrine Rev 1994;15:233–260.
16.
Pan B, Castro-Lopez JM, Coimbra A: Chemical sensory deafferentation abolishes hypothalamic pituitary activation induced by noxious stimulation or electroacupuncture but only decreases that caused by immobilization stress: A c-fos study. Neuroscience 1997;78:1059–1068.
17.
Kiss A, Aguilera G: Regulation of the hypothalamic pituitary adrenal axis during chronic stress: Responses to repeated intraperitoneal hypertonic saline injection. Brain Res 1993;630:262–270.
18.
Armario A, Jolín T: Influence of intensity and duration of exposure to various stressors on serum TSH and GH levels in adult male rats. Life Sci 1989;44:215–221.
19.
Armario A, Martí J, Gil M: The serum glucose response to acute stress is sensitive to the intensity of the stressor and to habituation. Psychoneuroendocrinology 1990;15:341–347.
20.
Armario A, Gil M, Martí O, Balasch J: Influence of various acute stressors on the activity of adult male rats in a holeboard and in the forced swim test. Pharmacol Biochem Behav 1991;39:373–377.
21.
Kvetnansky R, Mikulaj R: Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 1970;87:738–743.
22.
Lahmame A, Gómez F, Armario A: Fawn-hooded rats show enhanced active behaviour in the forced swimming test, with no evidence for pituitary-adrenal axis hyperactivity. Psychopharmacology 1996;125:74–78.
23.
Cook DM, Greer MA, Kendall JW: The half-life of endogenous immunoreactive ACTH in rat plasma. Proc Soc Exp Biol Med 1972;139:972–974.
24.
Rivier C, Vale W: Diminished responsiveness of the hypothalamo-pituitary-adrenal axis of the rat during exposure to prolonged stress: A pituitary-mediated mechanism. Endocrinology 1987;121:1320–1328.
25.
Martí O, Andrés R, Armario A: ACTH response to stress in previously stressed rats: Dependence on glucocorticoid status. Am J Physiol 1999;277:R869–R877.
26.
Graessler J, Kvetnansky R, Jezova D, Dobrakovova M, Van Loon GR: Prior immobilization stress alters adrenal hormone responses to hemorrhage in rats. Am J Physiol 1989;257:R661–R667.
27.
Keller-Wood M, Shinsako J, Dallman MF: Integral as well as proportional adrenal responses to ACTH. Am J Physiol 1983;245:R53–R59.
28.
Perrin F, Normand M, Fortier C: Analysis through mathematical models of the dynamics of the adrenal cortical response to ACTH in the rat. Ann Biomed Eng 1978;6:1–15.
29.
Normand M, Lalonde J: Studies on the dynamics of adrenocortical responses to ACTH in the rat. Mol Cell Endocrinol 1982;27:97–106.
30.
De Kloet ER, Oitzl MS, Joels M: Functional implications of brain corticosteroid receptor diversity. Cell Mol Neurobiol 1993;13:433–455.
31.
Armario A, Hidalgo J, Giralt M: Evidence that the pituitary-adrenal axis does not cross-adapt to stressors: Comparison to other physiological variables. Neuroendocrinology 1988;47:263–267.
32.
Martí O, Armario A: Anterior pituitary response to stress: Time-related changes and adaptation. Int J Dev Neurosci 1998;16:241–260.
33.
Pitman DL, Ottenweller JE, Natelson BH: Effect of stressor intensity on habituation and sensitization of glucocorticoid responses in rats. Behav Neurosci 1990;104:28–36.
34.
Orr TE, Meyerhoff JL, Mougey EH, Bunnell BN: Hyperresponsiveness of the rat neuroendocrine system due to repeated exposure to stress. Psychoendocrinology 1990;15:317–328.
35.
Ma XM, Aguilera G: Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Mol Brain Res 1999;68:129–140.
36.
Riccio DC, MacArdy EA, Kissinger SC: Associative processes in adaptation to repeated cold exposure in rats. Behav Neurosci 1991;105:599–602.
37.
Németh S, Vigas M, Jurcovicová J: Shortened ACTH response to trauma in repeatedly injured rats. Horm Metab Res 1975;7:101–107.
38.
De Boer SF, Koopmans SJ, Slangen JL, Van der Gugten J: Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: Effect of interstressor interval length. Physiol Behav 1990;4:1117–1124.
39.
Herman JP, Cullinan WE: Neurocircuity of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997;20:78–84.
40.
Chrousos GP, Gold PW: The concepts of stress and stress system disorders. JAMA 1992;267:1244–1252.
41.
Huether G: The central adaptation syndrome: Psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Prog Neurobiol 1996;48:569–612.
42.
Schürmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Cutler GB Jr, Loriaux DL, Chrousos GP: Human corticotropin-releasing factor in man: Pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortical secretion. J Clin Endocrinol Metab 1984;59:1103–1108.
43.
Stalla GJ, Hartwimmer J, Schopohl J, von Werder K, Müller A: Intravenous application of ovine and human corticotropin releasing factor (CRF): ACTH, cortisol, and CRF levels. Neuroendocrinology 1986;42:1–5.
44.
Sapolsky RM, Krey LC, McEwen BS: Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 1984;114:287–292.
45.
Martí O, Gavaldà A, Gómez F, Armario A: Direct evidence for chronic stress-induced faciliation of the adrenocorticotropin response to a novel acute stressor. Neuroendocrinology 1994;60:1–7.
46.
Makino S, Smith MA, Gold PW: Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 1995;136:3299–3309.
47.
Gómez F, Lahmame A, de Kloet ER, Armario A: Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: Differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996;63:327–337.
48.
Vernikos J, Dallman M, Bonner C, Katzen A, Shinsako J: Pituitary-adrenal function in rats chronically exposed to cold. Endocrinology 1982;110:413–419.
49.
Young EA, Akana S, Dallman MF: Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats. Neuroendocrinology 1990;51:536–542.
50.
Feldman S, Weidenfeld J: Neural mechanisms involved in the corticosteroid feedback effects on the hypothalamo-pituitary-adrenocortical axis. Prog Neurobiol 1995;45:129–141.
51.
Jessop DS: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J Endocrinol 1999;160:169–180.
52.
Pezzone MA, Lee W-S, Hoffman GE, Rabin BS: Induction of c-fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res 1992;597:41–50.
53.
Smith MA, Banerjee S, Gold PW, Glowa J: Induction of c-fos mRNA in rat brain by conditioned and unconditioned stressors. Brain Res 1992;578:135–141.
54.
Beck CHM, Fibiger HC: Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment. J Neurosci 1995;15:709–720.
55.
Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ: Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 1995;64:477–505.
56.
Panksepp J: The Foundations of Human and Animal Emotions. New York, Oxford University Press, 1998.
57.
Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ: Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginin vasopressin (AVP) mRNA expression. Brain Res 1992;592:228–238.
58.
Dobracovová M, Kvetnansky R, Torda T, Murgas K: Changes of plasma and adrenal catecholamines and corticosterone in stressed rats with septal lesions. Physiol Behav 1981;29:41–45.
59.
Herman JP, Cullinan WE, Morano MI, Akil H, Watson SJ: Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol 1995;7:475–482.
60.
Diorio D, Viau V, Meaney M: The role of medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamo-pituitary-adrenal responses to stress. J Neurosci 1993;13:3839–3847.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.